Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Coscia

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Neurochemistry|February 7, 1998
Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunitsM M Belcheva, Z Vogel, E Ignatova, et al.
Brain Research|March 1, 1987
Exogenous cholecystokinin (CCK) reduces neonatal rat brain opioid receptor density and CCK levelsF E Johnson, C Hudd, M C LaRegina, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cellsM M Belcheva, S Gucker, D M Chuang, et al.
Cancer|January 5, 1999
Kappa-opioid receptor binding varies inversely with tumor grade in human gliomasE C Pan, L M Bohn, M M Belcheva, et al.
American Journal of Surgery|December 1, 1991
Distribution and metabolism of doxorubicin in rats undergoing testicular circulatory isolationH Arakawa, K J Mueller, W G Doubek, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Buprenorphine differentially alters opioid receptor adaptation in rat brain regionsM M Belcheva, M T Ho, E G Ignatova, et al.
Brain Research. Molecular Brain Research|March 1, 1991
A monoclonal anti-idiotypic antibody to mu and delta opioid receptorsC J Coscia, M Szücs, J Barg, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1980
Effects of norlaudanosolinecarboxylic acids on enzymes of catecholamine metabolismC J Coscia, W J Burke, M P Galloway, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Neurochemistry|February 7, 1998
Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunitsM M Belcheva, Z Vogel, E Ignatova, et al.
Brain Research|March 1, 1987
Exogenous cholecystokinin (CCK) reduces neonatal rat brain opioid receptor density and CCK levelsF E Johnson, C Hudd, M C LaRegina, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cellsM M Belcheva, S Gucker, D M Chuang, et al.
Cancer|January 5, 1999
Kappa-opioid receptor binding varies inversely with tumor grade in human gliomasE C Pan, L M Bohn, M M Belcheva, et al.
American Journal of Surgery|December 1, 1991
Distribution and metabolism of doxorubicin in rats undergoing testicular circulatory isolationH Arakawa, K J Mueller, W G Doubek, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Buprenorphine differentially alters opioid receptor adaptation in rat brain regionsM M Belcheva, M T Ho, E G Ignatova, et al.
Brain Research. Molecular Brain Research|March 1, 1991
A monoclonal anti-idiotypic antibody to mu and delta opioid receptorsC J Coscia, M Szücs, J Barg, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1980
Effects of norlaudanosolinecarboxylic acids on enzymes of catecholamine metabolismC J Coscia, W J Burke, M P Galloway, et al.
Pageof 8